Stereotactic Body Radiation Therapy Market Size, Share and Global Trend By Type (Electron-Emitting High-Energy Linear Accelerators (Linac), Proton beam Therapy, Gamma Knife), By End User (Hospitals & Specialty Clinics, Cancer Radiotherapy Centres, Ambulatory Surgical Center, others)and Regional Forecast, 2024-2032

When radiation beams are focused on the body rather than the brain then the procedure is known as stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR). Stereotactic body radiotherapy is used to treat tumor’s in the lungs, neck, lymph node, spine, liver or other soft tissues. 3D imaging is used during stereotactic body radiotherapy which targets high doses of radiation at the affected area.

They offer greater advantages than tradition therapies by delivering a greater combined dose of radiations reducing the side effects in patients. Growing prevalence of lung & lymph node cancer and demand for effective therapies in the treatment of cancer are likely to fuel the growth of stereotactic body radiation therapy during the forecast period.

Growing prevalence of various cancers, growing launches of technologically advanced radiation therapies by many key players, and an increase in the demand for effective radiation therapy for the treatment of cancers are likely to drive the growth of stereotactic body radiation therapy market during the forecast period.

Additionally, benefits offered using stereotactic radiation therapy such as reduced acute and chronic radiation adverse effects as compared to the conventional radiation therapy and improved convenience for patients owing to shorter treatment duration, are some of the major factors expected to drive the adoption of stereotactic body radiation therapy during the forecast period.

However, lack of awareness in emerging countries about the advanced stereotactic body radiation therapies, high cost of therapy, and lack of reimbursement policies are some of the factors likely to restrain the growth of the global stereotactic body radiation therapy market during the forecast period.

Key Players Covered

Some of the major companies that are present in the global stereotactic body radiation therapy market are Siemens, Medical Systems, Inc., Elekta AB, IBA Worldwide 2019, BD, Isoray Inc., Accuray Incorporated, Mevion Medical Systems, Nordion Inc, Mallinckrodt, others.

SEGMENTATION 

Based on the product type, gamma knife segment is likely to expand at the highest growth rate during the forecast period as they are highly efficient and minimally invasive technique compared to other technique for the treatment of patients with cancer.

Key Insights

• Technological Advancements in Stereotactic Body Radiation Therapy
• Regulatory Scenario for Key Countries/Regions
• Recent Industry Developments Such as Partnerships, Mergers, and Acquisitions

Regional Analysis

The global stereotactic body radiation therapy can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the stereotactic body radiation therapy market during the forecast period owing to the growing developments in healthcare infrastructure, leading to increased adoption of new advanced techniques for the treatment of cancer, and implementation of favorable reimbursement policies. Europe is anticipated to hold the next largest position in stereotactic body radiation market during the forecast period owing to the growing prevalence of cancer and increasing awareness about the advanced stereotactic body radiation therapies. The growth of stereotactic body radiation therapy market is likely to boost at a significant rate in Asia Pacific region owing to the growing patient population and surge in the investments by key players in research for the development of cost-effective and minimally invasive radiation therapy for the treatment of cancers.

Key Industry Developments

• In November 2018, HealthCare Global Enterprises Ltd. launched the new generation of Tomotherapy in India fully integrated 3D conformal and image-guided intensity-modulated radiation therapy (IG-IMRT) system, and the CyberKnife Robotic Radiosurgery System, a technology designed to deliver stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT).
• In March 2017, the National Comprehensive Cancer Network Launched Radiation Therapy Compendium that included all types of therapies including stereotactic body radiation therapy (SBRT).